Source: International Congress 2014 – ILDs 6
Disease area: Interstitial lung diseases

Abstract

Since 1974 till 2013 we observed around 3000 patients with proven sarcoidosis. Investigation included anamnesis, chest CT, US of abdomen, bronchoscopy with BAL and TBLB or VATS. All cases were confirmed by morphology. Non-typical variants of disease were observed in 66 cases (3,3%).Of them, further variants of clnical course were observed:sarcoidosis with symptoms of lymphoid proliferation (subfebrile fever, spleno- and hepatomegaly, peripheral lymphnodes impairment) – 12 cases.sarcoidosis with progressive pneumosclerosis and growing breathlessness (like in IPF cases) – 26 cases.Infiltrative and pneumonic forms of disease with conglomerates and atelectases in the lung (like in infiltrative TB) – 28 cases.Duration of observation over our patients reached 17 years in maximal. All cases were with recurrent form of disease. Overall mortality in studied cohort reached 13.6 % (9 cases).Conclusion: All atypical variants of clinical flow of sarcoidosis were prognostically non-favourable. All these cases need advanced investigation and prolonged and intensive treatment.

Rating:

Share or cite this content

Citations should be made in the following way:
V. Romanov (Moscow, Russian Federation). Atypical variants of clinical course of sarcoidosis. Eur Respir J 2014; 44: Suppl. 58, 3782

Member's Comments

No comment yet.

Related content which might interest you: Predictors of cardiovascular events in newly diagnosed patients with sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Extrapulmonary involvement in sarcoidosis patients Source: International Congress 2014 – ILDs 4 Year: 2014 Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients Source: International Congress 2014 – Sarcoidosis Year: 2014 Clinical features and prognosis of 108 patients with lymphangioleiomyomatosis Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Cognitive failure in sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study Source: International Congress 2014 – Sarcoidosis Year: 2014 Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study Source: International Congress 2014 – Sarcoidosis Year: 2014 Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome Source: International Congress 2014 – ILDs 1 Year: 2014 Pregnancy course in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Aetiological panorama in the diagnosis of interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Microscopic polyangiitis: Type of interstitial pneumonitis on chest HRCT and the clinical features Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Reduction in disease progression with nintedanib in the INPULSIS™ trials Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Cystic lung disease with pulmonary amyloidosis: Analysis of 21 patients Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Huge bilaterally cavitary and nodulary lung lesions: Pulmonary lenfomatoid granulomatosis Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Serum levels of sestrin 2 in patients with sarcoidosis Source: International Congress 2014 – ILDs 6 Year: 2014 Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary? Source: International Congress 2014 – ILDs 4 Year: 2014 Clinical features of four children with pulmonary alveolar proteinosis Source: International Congress 2014 – ILDs 5 Year: 2014 Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Benefit of steroid-free treatment compared to standard therapy (ST) in pulmonary sarcoidosis Source: International Congress 2014 – ILDs 5 Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone Source: International Congress 2014 – Clinical trials in IPF Year: 2014